Management of myocarditis-related cardiomyopathy in adults

C Tschöpe, LT Cooper, G Torre-Amione… - Circulation …, 2019 - Am Heart Assoc
Myocarditis is generally a mild and self-limited consequence of systemic infection of
cardiotropic viruses. However, patients can develop a temporary or permanent impairment …

[HTML][HTML] Myocarditis in humans and in experimental animal models

P Błyszczuk - Frontiers in cardiovascular medicine, 2019 - frontiersin.org
Myocarditis is defined as an inflammation of the cardiac muscle. In humans, various
infectious and non-infectious triggers induce myocarditis with a broad spectrum of …

Fulminant versus acute nonfulminant myocarditis in patients with left ventricular systolic dysfunction

E Ammirati, G Veronese, M Brambatti, M Merlo… - Journal of the American …, 2019 - jacc.org
Background: Fulminant myocarditis (FM) is a form of acute myocarditis characterized by
severe left ventricular systolic dysfunction requiring inotropes and/or mechanical circulatory …

[HTML][HTML] Chinese society of cardiology expert consensus statement on the diagnosis and treatment of adult fulminant myocarditis

D Wang, S Li, J Jiang, J Yan, C Zhao, Y Wang… - Science China Life …, 2019 - Springer
Fulminant myocarditis is primarily caused by infection with any number of a variety of
viruses. It arises quickly, progresses rapidly, and may lead to severe heart failure or …

Fulminant myocarditis: epidemiology, pathogenesis, diagnosis, and management

AN Sharma, JR Stultz, N Bellamkonda… - The American Journal of …, 2019 - Elsevier
Fulminant myocarditis (FM) is a rare, distinct form of myocarditis that has been difficult to
classify. Since 1991, the definition of FM has evolved, and it is currently considered an acute …

A life support-based comprehensive treatment regimen dramatically lowers the in-hospital mortality of patients with fulminant myocarditis: a multiple center study

S Li, S Xu, C Li, X Ran, G Cui, M He, K Miao… - Science China Life …, 2019 - Springer
Fulminant myocarditis (FM) has unacceptable high mortality. This study aimed to evaluate
the therapeutic efficacy of a life support-based comprehensive treatment regimen (LSBCTR) …

Myocarditis in the pediatric population: a review

S Dasgupta, G Iannucci, C Mao… - Congenital Heart …, 2019 - Wiley Online Library
Myocarditis has a variable clinical presentation and there is still debate regarding accurate
diagnostic criteria. Adding to the controversy surrounding this diagnosis, there is no clear …

State of the art: Evaluation and prognostication of myocarditis using cardiac MRI

MP Gannon, E Schaub, CL Grines… - Journal of Magnetic …, 2019 - Wiley Online Library
Myocarditis encompasses both primary and secondary processes causing inflammation of
the myocardium. Viral infections are a common secondary cause of myocarditis with …

[HTML][HTML] Role of intravenous immunoglobulin therapy in the survival rate of pediatric patients with acute myocarditis: A systematic review and meta-analysis

CY Yen, MC Hung, YC Wong, CY Chang, CC Lai… - Scientific reports, 2019 - nature.com
The treatment of pediatric myocarditis is controversial, and the benefits of intravenous
immunoglobulin (IVIG) are inconclusive due to limited data. We searched studies from …

Severe heart failure and the need for mechanical circulatory support and heart transplantation in pediatric patients with myocarditis: results from the prospective …

S Schubert, B Opgen‐Rhein, M Boehne… - Pediatric …, 2019 - Wiley Online Library
Myocarditis represents an important cause for acute heart failure. MYKKE, a prospective
multicenter registry of pediatric patients with myocarditis, aims to gain knowledge on …